Back to Results

EFTA00489740.pdf

Source: DOJ_DS9  •  Size: 85.0 KB  •  OCR Confidence: 85.0%
PDF Source (No Download)

Extracted Text (OCR)

From: Lesley Groff To: Jefffrey Epstein <jeevacation@gmail.com>, Rich Kahn < Subject: Date: Thu, 17 Jan 2019 17:19:49 +0000 Inline-Images: 1506365439123blobjpg; 1506365439123blob(1).jpg > equested I forward you the below 'catch up' email. BioHcbe LLC cell: email: www.biohebe.com 011itoHehe ;11nline image -- Forwarded Message --- From To: je . leevacation@gmail.com>; Sent: Wednesday, January 16, 2019, 11:22:06 PM EST Subject: Catching Up Dear Jeffrey I hope you've been well. I wanted to update you on what I've been up to for the last two years. I was also hoping to talk with you to see if I might use the foundation's Lexington office conference room from time to time for my work and what I could provide in exchange for that. I am cc'ing Rich because I'm not sure if you still use this email? Since working for your foundation, I continued to publish as a joumalist writing mostly about genetic vectors (Newsweek, Techonomy etc). I then set up an LLC that provides business development for labs that have reversed age-driven or degenerative diseases. Most of the therapies are genetic vectors, and have to show remarkable results at the mouse level and beyond. Regenerative medicine is a rapidly evolving field, and one that forces the medical industry to shift their focus from addressing symptoms of disease to fundamental evolutionary shortfalls. So far, I placed a genetic vector at the National Institute of Medicine in France (that reversed glaucoma in mice using the neuroglobin gene) under formal licence review with a publicly traded pharma group here in the US. And I am collaborating with a lab at the University of Pittsburgh that has reversed cirrhosis/ end stage liver disease in rats using the master transcription gene in hepatocytes. The concept of the latter gene vector is really EFTA00489740 intriguing in that a master transcription gene completely restored liver function by rebalancing genetic expression and thus proteostasis. While I don't really need an office at this point, I do need access to a conference mom from time to time and it would be hugely helpful if I could access the foundation's. If there was some work that I could do for the foundation in exchange, I would be delighted to do that. It would be wonderful to catch up with you as well. all the best, BioHebe LLC cell: email: www.biohebe.com ceBioHebe ;Janne image EFTA00489741

Document Preview

PDF source document
This document was extracted from a PDF. No image preview is available. The OCR text is shown on the left.

Document Details

Filename EFTA00489740.pdf
File Size 85.0 KB
OCR Confidence 85.0%
Has Readable Text Yes
Text Length 2,427 characters
Indexed 2026-02-11T22:14:38.165463
Ask the Files